PharmacoepidemiologyRoutledge, 19 dic 2018 - 360 páginas This volume is comprised of papers presented at the Third International Conference on Pharmacoepidemiology, held September 9-11, 1987, in Minneapolis, Minnesota. The book is divided into four sections, which reflect the four themes of the conference: Social Impact of Pharmacoepidemiology; Drug Epidemiology and the Law; Drug Surveillance; and Drugs, Populations, and Outcomes: Specific Studies. The collection of papers discusses the social and legal impact of epidemiology, the system of checks and balances that is necessary for the field, the importance of core support for researchers, and the goal of an enlightened and informed public, including the media, consumer advocates, and the courts. Contributing authors offer perspectives from academia, practice, government, industry and the law. Numerous tables and figures are included to illustrate many of the papers within the text. This book offers substantial reading for epidemiologists and individuals interested in the field of pharmacoepidemiology. |
Índice
Introduction | |
Industry Perspectives and the Contributions of Pharmacoepidemiology | |
Introduction | |
Anatomy of an Intellectual | |
Introduction | |
Evaluation of First Year Experience of a State Pilot Project to Promote | |
Monitoring System for Adverse Events Following Immunization Risk | |
Application of a New Method for Adverse Experience Monitoring | |
Overcoming Limitations of Routine Surveillance of Drug Overdose | |
Early Experience with the COMPASS Data Base by Jeffrey L Carson | |
Impact of Nonsteroidal Antiinflammatory Agents on General | |
The Relationship Between Rheumatoid Arthritis and Risk of Cancer | |
CreutzfeldtJakob Disease Human Growth Hormone and Its Replacement | |
Differences in Psychotropic Medications Reported Used by Blacks | |
Psychotropic Drug Use and Health Outcomes in Nursing Homes | |
Appendix | |
Otras ediciones - Ver todo
Términos y frases comunes
acyclovir adverse drug reactions adverse events adverse experiences adverse reaction reporting aminoglycosides analysis antibiotics antidepressants anxiolytics assessment associated Bendectin birth defects cancer causation cimetidine clinical trials court creatinine Creutzfeldt-Jakob disease data base diagnoses diclofenac differences disease DMARD dose Drug Administration Drug Surveillance effect elderly epidemiologic epidemiologic studies estimated evaluation evidence expert follow-up Food and Drug frequency gastrointestinal history of convulsions hospital ibuprofen included increase infection intensive care unit Judge Shoob length of stay liability males monitoring nephrotoxicity nonsteroidal antiinflammatory drugs NSAIDs outcome overdose patients with nephrotoxicity peptic ulcer pharmaceutical pharmacists pharmacoepidemiology physicians piroxicam plaintiffs population postmarketing surveillance potential prescribed prescription problem psychotropic drug psychotropic medications records regression regulatory relative risk reporting rates Retrovir scientific serum specific spermicides spontaneous reports statistically significant study group sulindac symptoms Table testimony theophylline therapeutic toxicity UGI bleeding upset vaccine variables versus